Tingting Liu

Tingting Liu

Auto-generated profile, based on publicly available information

Tingting Liu

Department of Medicinal Chemistry, School of Pharmacy, State Key Laboratory of Advanced Drug Delivery and Release Systems, Shandong First Medical University, Jinan, Shandong, 250117, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TLTingting Liu
Tingting Liu
YWYichao Wan
Yichao Wan
YXYuliang Xiao
Yuliang Xiao
CXChengcai Xia
Chengcai Xia
GDGuiyun Duan
Guiyun Duan

1 January 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TLTingting Liu
Tingting Liu
SSShubin Song
Shubin Song
XWXu Wang
Xu Wang
JHJifu Hao
Jifu Hao

13 December 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JZJie Zhang
Jie Zhang
YGYuqi Gao
Yuqi Gao
ZZZipeng Zhang
Zipeng Zhang
JZJinbo Zhao
Jinbo Zhao
WJWenshuang Jia
Wenshuang Jia
TLTingting Liu
Tingting Liu

1 September 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TLTingting Liu
Tingting Liu
ZWZhongyu Wu
Zhongyu Wu
YHYujing He
Yujing He
YXYuliang Xiao
Yuliang Xiao
CXChengcai Xia
Chengcai Xia

9 April 2020 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
YWYichao Wan
Yichao Wan
CYChunxing Yan
Chunxing Yan
HGHan Gao
Han Gao
TLTingting Liu
Tingting Liu
Proteolysis-targeting chimera (PROTAC) is a new technology to selectively degrade target proteins via ubiquitin-proteasome system. PROTAC molecules (PROTACs) are a class of heterobifunctional molecules, which contain a ligand targeting the protein of interest, a ligand recruiting an E3 ligase and a linker connecting these two ligands. They provide several advantages over traditional inhibitors in potency, selectivity and drug resistance. Thus, many promising PROTACs have been developed in the recent two decades, especially small-molecule PROTACs. In this review, we briefly introduce the mechanism of PROTACs and focus on the progress of small-molecule PROTACs based on different E3 ligases. In addition, we also introduce the opportunities and challenges of small-molecule PROTACs for cancer therapy.

1 May 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ZZZheng Zhang
Zheng Zhang
XXXiaolan Xing
Xiaolan Xing
PGPeng Guan
Peng Guan
SSShubin Song
Shubin Song
GYGuirong You
Guirong You
TLTingting Liu
Tingting Liu